In glioblastoma, overexpression of RBFOX1 was found to increase the blood-tumor barrier permeability by increasing the stability of MAFF, which promoted doxorubicin delivery across the blood-tumor barrier, resulting in apoptosis of glioma cells (16). This evidence concerns the gene RBFOX1 and neoplasm.